FCBN425QP1C07 Pricing (USD) [88PC Stock]
- 1 pcs$402.21898
- Nimewo Pati:
- FCBN425QP1C07
- Manifakti:
- Finisar Corporation
- Detaye deskripsyon:
- CABLE OPT 4X25G OMNI-PATH QSFP C. Fiber Optic Cable Assemblies 4x25G, full-duplex, Omni-Path, QSFP cable ends, electrical limiting interface, RoHS, multimode, 0/70 C operation. Internal optics: 850nm VCSEL array, PIN array, round plen
- Manufacturer's standard lead time:
- Nan stok
- Lavi etajè:
- Yon ane
- Chip Soti nan:
- Hong Kong
- RoHS:
- Metòd peman:
-
- Chemen chajman:
- Kategori Fanmi yo:
- KEY Composants Co., LTD se yon Distribitè Eleman Elektwonik ki ofri kategori pwodwi ki gen ladan: Barik - Cables pouvwa, Kablè kole yo, Flat Flex, Riban kavalye Riban, Solid State Lighting Cables, D-Sub Cables, Asanble kab rektangilè, D-ki gen fòm, Cables Centronics and Cables LGH ...
- Avantaj konpetitif:
- We specialize in Finisar Corporation FCBN425QP1C07 electronic components. FCBN425QP1C07 can be shipped within 24 hours after order. If you have any demands for FCBN425QP1C07, Please submit a Request for Quotation here or send us an email: rfq@key-components.com
FCBN425QP1C07 Atribi pwodwi yo
Nimewo Pati :
FCBN425QP1C07
Manifakti :
Finisar Corporation
Deskripsyon :
CABLE OPT 4X25G OMNI-PATH QSFP C
Seri :
-
Estati Pati :
Active
Kab Connectors :
-
Kantite Pozisyon yo :
-
Kalite Connector :
-
Sèks :
-
Kalite fiksasyon :
-
Karakteristik :
-
Kab Kalite :
-
Itilizasyon :
-
Longè :
-
Koulè :
-
Pwoteksyon :
-
Dènye nouvèl
Ou ka enterese tou
-
-
FCCN410QD3CX0
Finisar Corporation
CABLE QSFP M-M 100M. Fiber Optic Cable Assemblies Fiber Optic Cable Assemblies
-
FCBN425QB1C03
Finisar Corporation
CABLE QSFP28 M-M 3M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
-
FCBN425QB1C05
Finisar Corporation
CABLE QSFP28 M-M 5M. Fiber Optic Cable Assemblies 100G QSFP28 QSFP AOC
-
-
FCBGD10CD1C03
Finisar Corporation
CABLE ASSY CXP M-M 3M. Fiber Optic Cable Assemblies 12x10Gbps Optical CXP AOC
Pati cho
- 10124109-2090LF
- FCBN414QB1CX0
- FCBR425QB1C30
- FCBN425QE1C10
- AFBR-7QER01Z
- QSSFP-P01M0-1
- 6A11-A0121-080.0-0
- 0745261003
- FCBG110SD1C01B
- FCF8-20-01-L-13.90-S
- ICD040GVP163D-01
- 2083110-5
- 0745570001
- 1110401705
- 1002971215
- 2083109-5
- 10127771-2030LF
- 10117984-4060HLF
- 6A44-B0421-014.0-0
- 6A22-A0421-001.0-0
- FCBND12CD1CX0
- PCIEO-4G3-010.0-11
- 6A44-B0441-017.0-0
- 10120612-2090LF
- PCIEC-098-0300-EC-EM-P
- 6A22-D0421-017.0-0
- ICD150GVP341A-50
- 6A22-A0441-050.0-0
- ICD040GVP163D-20
- 10127773-2090LF
- 0745063001
- FCBP110LD1L10
- 1110404805
- 6A22-A0441-027.0-0
- 10127771-2040LF
- ICD120GVP2410-20
- FCBP110LD1L03S
- 0745951060
- 10111728-15S300HLF
- 10115006-7SS146HLF